(Q44255432)

English

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

scientific article

Statements

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients (English)
N Harbeck
M Schmitt
C Meisner
C Friedel
C G J Sweep
B W Lisboa
S Hasmüller
M Kiechle
F Jänicke
C Thomssen
Chemo-N 0 Study Group
13 March 2013
1825-1835

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit